期刊文献+

真核表达载体pEGFP-N2/AT2R的构建及其在原代血管平滑肌细胞的表达

Construction of eukaryotic expressing vector pEGFP-N2/AT2R and its expression in primary vascular smooth muscle cells
下载PDF
导出
摘要 目的体外构建携带血管紧张素Ⅱ2型受体(ANGⅡType 2 Receptor,AT2R)基因的增强型绿色荧光蛋白真核表达载体,并观察其在大鼠血管平滑肌细胞(vascular smooth muscle cells,VSMCs)中的表达。方法以pUHD-10.3/AT2R质粒为模板,PCR扩增AT2R基因的全长cDNA序列,再将其克隆入载体pEGFP-N2,构建其真核表达载体pEGFP-N2/AT2R。以基因转染技术,将AT2R导入原代VSMCs。倒置荧光显微镜观测转染后VSMCs生长变化及AT2R在其中的表达等情况。图像分析技术检测AT2R在VSMCs中的转染效率。Western blot检测转染AT2R基因的VSMCs表达其编码蛋白。RT-PCR法对AT2R基因修饰的VSMCs进行鉴定。结果成功构建AT2R基因的真核表达载体pEGFP-N2/AT2R,该真核载体能携带AT2R基因转染并有效表达于VSMCs,其转染效率约40%,RT-PCR及Western blot均可检测到AT2RmRNA及蛋白在血管平滑肌细胞中高表达。结论成功地将克隆到的AT2R基因克隆入pEGFP-N2载体中,并实现了AT2R基因在原代VSMCs的表达。 Objective To clone Ang Ⅱ type 2 receptor(AT2R) gene,obtain enhanced green fluorescent protein(EGFP) vector for the gene,and then observe its expression in primary vascular smooth muscle cells(VSMCs) after transfection.Methods Utilizing plasmid pUHD-10.3/AT2R as a template,the full length cDNA fragment of AT2R was amplified by polymerase chain reaction(PCR).Eukaryotic expression vector pEGFP-N2/AT2R was constructed by cloning AT2R gene into vector pEGFP-N2.After transfecting AT2R into primarily cultured VSMCs,invert fluorescent microscopy was employed to observe VSMCs growth as well as AT2R expression in VSMCs.Transfection efficiency of AT2R in VSMCs was evaluated by image analyzor,the protein and mRNA expressions of AT2R in VSMCs were examined by Western blotting and RT-PCR.Results Eukaryotic expression vector pEGFP-N2/AT2R was successfully constructed.The eukaryotic vector expressing AT2R gene was efficiently transfected and expressed in VSMCs.The transfection efficiency of AT2R gene in VSMCs was about 40%.RT-PCR and Western blotting indicated that AT2R was expressed in cultured VSMCs at mRNA and protein levels.Conclusion cDNA sequence encoding AT2R gene is successfully cloned into pEGFP-N2 which can be efficiently expressed in primary VSMCs.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第9期940-943,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(30670521)~~
关键词 血管紧张素Ⅱ2型受体基因 克隆 原代血管平滑肌细胞 绿色荧光蛋白 Ang Ⅱ type 2 receptor cloning primary vascular smooth muscle cells enhanced green fluorescent protein
  • 相关文献

参考文献14

  • 1Bosiers M, Deloose K, Keirs K, et al. Prevention and treatment of in-stent restenosis[J]. J Cardiovasc Surg (Torino), 2010, 51(4): 591 -598.
  • 2Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents[J]. Circ J, 2009, 73(4) : 615 -621.
  • 3Vorpahl M, Virmani R, Ladich E, et al. Vascular remodeling after coronary stent implantation [ J ]. Minerva Cardioangiol, 2009, 57 (5) : 621 - 628.
  • 4Sata M, Fukuda D. Crucial role of renin-angiotensin system in the path- ogenesis of atherosclerosis[J].J Med Invest, 2010, 57( 1/2): 12 -25.
  • 5Lemarie C A, Schiffrin E L. The angiotensin II type 2 receptor in cardiovascular disease[ J ]. J Renin Angiotensin Aldosterone Syst, 2010, 11(1): 19-31.
  • 6苗莉,何国祥,景涛,蒋清安,江明宏,刘建平.观察大鼠血管平滑肌细胞与间充质干细胞直接接触培养对细胞的诱导分化[J].第三军医大学学报,2007,29(9):814-816. 被引量:3
  • 7Throndson K, Sawatzky J A. Angina following percutaneous coronary intervention : in-stent restenosis[J]. Can J Cardiovasc Nurs, 2009, 19 (3) : 16 -23.
  • 8Tiroch K A, Byrne R A, Kastrati A. Pharmacological prevention and management of restenosis [ J ]. Expert Opin Pharmacother, 2010, 11 (11) : 1855 -1872.
  • 9Jing T, Wang H, Srivenugopal K S, et al. Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metaUoproteinase 2 expression and vascular remodeling [ J ]. Int J Mol Med, 2009, 24 (1): 103- 110.
  • 10Jones E S, Vinh A, McCarthy C A, et al. AT2 receptors: functional relevance in cardiovascular disease[ J ]. Pharmacol Ther, 2008, 120 (3) : 292 -316.

二级参考文献36

  • 1唐兵,何国祥,李德,黎军.大鼠血管紧张素Ⅱ2型受体基因转染对颈动脉球囊损伤后新生内膜形成的影响[J].中国介入心脏病学杂志,2005,13(2):108-110. 被引量:3
  • 2Browatzki M, Larsen D, Pfeiffer C A, et al. Angiotensin Ⅱ stimu- lates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner[J]. J Vasc Res, 2005, 42 (5) : 415 - 423.
  • 3Burzotta F, Siviglia M, Ahamura L, et al. Outcome of overlapping her-erogenous drug-eluting stents and of overlapping drug-etuting and bare metal stents[J]. Am J Cardiol, 2007, 99(3) : 364-368.
  • 4Crook M F, Akyurek L M. Gene transfer strategies to inhibit neointima formatign [J]. Trends Cardiovase Med, 2003, 13 (3) : 102-106.
  • 5Berk B C, Corson M A. Angiotensin II signal trausduction in vascular smooth muscle: role of tymsine kinases[J]. Circ Res, 1997, 80(6): 607-616.
  • 6Hsieh P S, Tai Y H, Loh C H, et al. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hyperten- sion in rats[J]. Metabolism, 2005, 54(2): 157-164.
  • 7Clowes A W, Reidy M A, Clowes M M. Kinetics of cellular prolifera- tion after arterial injury. I. Smooth muscle growth in the absence of en- dothelium[J]. Lab Invest, 1983, 49(3) : 327-333.
  • 8Seidler R W, Allgauer S, Ailinger S, et al. In vivo human MCP-1 transfection in porcine arteries by intravascular electmporation [ J ]. Pharm Res, 2005, 22(10): 1685-1691.
  • 9Martin J B, Young J L, Benoit J N, et al. Gene transfer to intact mesen- teric arteries by electroporation[J]. J Vasc Res, 2000, 37(5) : 372 -380.
  • 10Zargham R, Thibault G. alpha8betal integrin expression in the rat ca- rotid artery: involvement in smooth muscle cell migration and neointima formation[J]. Cardiovasc Res, 2005, 65(4): 813-822.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部